FDA Warns Hospira Over Infusion Pump Plant

The Food and Drug Administration (FDA) sent a warning letter to Hospira Inc. over quality issues at the manufacturing plant that produces most of the company’s infusion pumps.

The FDA cited issues with the company’s Plum brand infusion pump, a medical device which was recalled in February 2011 due to alarm problems, according to Reuters. The agency’s warning letter said that Hospira received complaints of alarm failures even after a supplier redesigned the part.

The letter resulted from an April inspection of the company’s plant in La Aurora de Heredia, Costa Rica.

A spokesperson for the company said it was switching alarm components for the pump, a process it expects to complete by early 2013.

If you or a loved one has been harmed by an unsafe medical device, contact Sokolove Law for a free legal consultation and to find out if a product liability lawyer may be able to help you.

Tags: